Literature DB >> 11994331

The role of thyroid hormone in blood pressure homeostasis: evidence from short-term hypothyroidism in humans.

Enza Fommei1, Giorgio Iervasi.   

Abstract

Arterial hypertension is known to be frequently associated with thyroid dysfunction, with a particularly high prevalence in chronic hypothyroidism. However, to our knowledge no comprehensive study addressed causal mechanisms possibly involved in this association. We here report the physiological relationships between blood pressure and neuro-humoral modifications induced by acute hypothyroidism in normotensive subjects. Twelve normotensive patients with previous total thyroidectomy were studied. Ambulatory 24-h blood pressure monitoring was performed, and free T(3), free T(4), TSH, PRA, aldosterone, cortisol, adrenaline, and noradrenaline were assayed 6 wk after oral L-T(4) withdrawal (phase 1) and 2 months after resumption of treatment (phase 2). During the hypothyroid state (TSH, 68.1 +/- 27.7 microIU/ml; mean +/- SD), daytime arterial systolic levels slightly, but significantly, increased (125.5 +/- 9.7 vs. 120.4 +/- 10.8 mm Hg; P < 0.05), and daytime diastolic levels (84.6 +/- 7.9 vs. 76.4 +/- 6.8 mm Hg; P < 0.001), noradrenaline (2954 +/- 1578 vs. 1574 +/- 962 pmol/liter; P < 0.001), and adrenaline (228.4 +/- 160 vs. 111.3 +/- 46.1 pmol/liter; P < 0.05) also increased. PRA remained unchanged (0.49 +/- 0.37 vs. 0.35 +/- 0.21 ng/ml.h; P = NS), whereas both aldosterone (310.3 +/- 151 vs. 156.9 +/- 67.5 pmol/liter; P < 0.005) and cortisol (409.2 +/- 239 vs. 250.9 +/- 113 pmol/liter; P < 0.02) significantly increased. By using univariate logistic regression daytime arterial diastolic values, noradrenaline and aldosterone were found to be significantly related to the hypothyroid state (P < 0.02, P < 0.036, and P < 0.024, respectively). In conclusion, our data show that thyroid hormones participate in the control of systemic arterial blood pressure homeostasis in normotensive subjects. The observed sympathetic and adrenal activation in hypothyroidism, which is reversible with thyroid hormone treatment, may also contribute to the development of arterial hypertension in human hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11994331     DOI: 10.1210/jcem.87.5.8464

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  34 in total

Review 1.  The role of thyroid hormone in the pathophysiology of heart failure: clinical evidence.

Authors:  E Galli; A Pingitore; G Iervasi
Journal:  Heart Fail Rev       Date:  2008-12-27       Impact factor: 4.214

2.  Evaluation of Daily Blood Pressure Alteration in Subclinical Hypothyroidism.

Authors:  Ismail Polat Canbolat; Erdal Belen; Akif Bayyigit; Aysen Helvaci; Kadriye Kilickesmez
Journal:  Acta Cardiol Sin       Date:  2017-09       Impact factor: 2.672

3.  Investigation of thyroid function and blood pressure in school-aged subjects without overt thyroid disease.

Authors:  Huanhuan Chen; Qian Xi; Hao Zhang; Bin Song; Xiaoyun Liu; Xiaodong Mao; Jie Li; Hongmei Shen; Wei Tang; Jiaming Zhang; Zhiguo Wang; Yu Duan; Chao Liu
Journal:  Endocrine       Date:  2011-08-30       Impact factor: 3.633

4.  Exercise training-induced changes in metabolic syndrome parameters, carotid wall thickness, and thyroid function in middle-aged women with subclinical hypothyroidism.

Authors:  Nayoung Ahn; Hye Soon Kim; Kijin Kim
Journal:  Pflugers Arch       Date:  2019-01-18       Impact factor: 3.657

5.  The impact of multiple single day blood pressure readings on cardiovascular risk estimation: The Atherosclerosis Risk in Communities study.

Authors:  Abayomi N Ogunwale; Alanna C Morrison; Wensheng Sun; Rhiannon C Dodge; Salim S Virani; Addison Taylor; Rebecca F Gottesman; Eric Yang; Peng Wei; John W McEvoy; Gerardo Heiss; Eric Boerwinkle; Christie M Ballantyne; Vijay Nambi
Journal:  Eur J Prev Cardiol       Date:  2016-02-11       Impact factor: 7.804

6.  Masked hypertension in newly diagnosed hypothyroidism: a pilot study.

Authors:  E Piantanida; D Gallo; G Veronesi; N Pariani; E Masiello; P Premoli; L Sassi; A Lai; M L Tanda; M Ferrario; L Bartalena
Journal:  J Endocrinol Invest       Date:  2016-05-19       Impact factor: 4.256

Review 7.  Hypothyroidism as a risk factor for cardiovascular disease.

Authors:  Bernadette Biondi; Irwin Klein
Journal:  Endocrine       Date:  2004-06       Impact factor: 3.633

8.  High prevalence of subclinical thyroid dysfunction and the relationship between thyrotropin levels and cardiovascular risk factors in residents of the coastal area of China.

Authors:  Jinqian Wang; Xiuyun Ma; Shuying Qu; Yingzheng Li; Lihui Han; Xun Sun; Peimei Li; Xue Liu; Jinhua Xu
Journal:  Exp Clin Cardiol       Date:  2013

9.  Maternal prolactin inhibition during lactation programs for metabolic syndrome in adult progeny.

Authors:  Egberto Gaspar de Moura; Isabela Teixeira Bonomo; José Firmino Nogueira-Neto; Elaine de Oliveira; Isis Hara Trevenzoli; Adelina Martha Reis; Magna Cottini Fonseca Passos; Patricia Cristina Lisboa
Journal:  J Physiol       Date:  2009-09-07       Impact factor: 5.182

10.  Association between insulin resistance and hypothyroidism in females attending a tertiary care hospital.

Authors:  Bhawna M Singh; B Goswami; V Mallika
Journal:  Indian J Clin Biochem       Date:  2010-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.